Friess Associates’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-501,611
Closed -$20.1M 140
2018
Q3
$20.1M Hold
501,611
1.41% 32
2018
Q2
$19.2M Buy
+501,611
New +$18.5M 1.52% 23

Other funds holding QGEN

Friess Associates's QGEN Position: Q4 2018 in Review

Friess Associates sold out of Qiagen (QGEN) in Q4 2018, closing a stake of 501,611 shares — an estimated $20.1M sold.

Friess Associates first reported a position in QGEN in Q2 2018 and held it in 2 quarters. The position peaked at $20.1M in Q3 2018. 251 funds tracked by Wall St. Rank hold QGEN as of Q4 2018.

  • Friess Associates reported no remaining Qiagen position as of Q4 2018 after selling out during the quarter.
  • Friess Associates sold 501,611 Qiagen shares in Q4 2018, an estimated $20.1M.
  • Friess Associates first reported a position in Qiagen in Q2 2018 and held it in 2 quarters.
  • Friess Associates's Qiagen position peaked at $20.1M in Q3 2018.
  • 251 funds tracked by Wall St. Rank held Qiagen as of Q4 2018.

Based on Friess Associates's 13F filing for Q4 2018, filed 14 Feb 2019.